What is DaVita Venture Group's approach to investing in healthcare technology?

DaVita Venture Group's approach to investing in healthcare technology involves seeking out innovative solutions that align with their mission to improve patient outcomes, particularly for those with kidney disease. They focus on technologies that drive clinical excellence and enhance the quality of care.

DaVita Venture Group is dedicated to investing in and partnering with innovators to provide strategic capital aimed at improving the lives of patients with kidney disease. They focus on various investment priorities including care models, digital health, new service lines, and life sciences. Their capabilities span venture capital, corporate development, and strategic partnerships.

• Invest up to $10M, stage agnostic
• Execute scale investments, acquisitions, and joint ventures
• Co-develop, pilot, and incubate new care models & technologies

More Questions About DaVita Venture Group

What is DaVita Venture Group?

DaVita Venture Group is a venture capital firm dedicated to investing in and partnering with innovators to provide strategic capital aimed at improving the lives of patients with kidney disease.

Where is DaVita Venture Group located?

DaVita Venture Group operates globally.

When was DaVita Venture Group founded?

This information is not publicly available.

What type of investor is DaVita Venture Group?

DaVita Venture Group is a venture capital firm.

Does DaVita Venture Group invest in Healthcare?

Yes, DaVita Venture Group invests in the Healthcare sector.

Does DaVita Venture Group invest in Biotech?

Yes, DaVita Venture Group invests in the Biotech sector.

Verification Confidence: 92% | Source: investment_thesis | Entity: DaVita Venture Group